NCT00296179 Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro Status COMPLETED Phase PHASE4
NCT00291005 PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone Status COMPLETED Phase PHASE2
NCT00290979 Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00290966 Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00290953 Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide Status COMPLETED Phase PHASE2/PHASE3
NCT00290927 Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00290030 ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH Status COMPLETED Phase PHASE3
NCT00289042 Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) Status COMPLETED Phase PHASE4
NCT00288236 Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO) Status COMPLETED Phase PHASE3
NCT00285415 A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation Status TERMINATED Phase PHASE2
NCT00285077 Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00285025 Study of the Effect of SR57667B in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00284141 Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00284128 AVE7688 in Patients With Mild to Moderate Blood Pressure Status COMPLETED Phase PHASE2/PHASE3
NCT00283829 Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2